Newsroom


Mar 25, 2010


Jan 08, 2010      


Colmesdant Receives Marketing Authorization in Mexico 

Gentalyn® Receives Marketing Authorization in Chile

   

Sep 23, 2009

 BurnsAdler Partners with Three Rivers Pharmaceuticals to Commercialize Infergen® in Brazil and Chile
   
Sep 10, 2008 BurnsAdler Announces Named Patient Access Program for Latin America in Collaboration with DOR BioPharma
   

Mar 24, 2008

 Collatamp™ EG Receives Marketing Authorization in Brazil
   
Mar 05, 2007  BurnsAdler Partners with X-GEN to Return Colistimethate for Injection to the Mexican Market
   
Jan 09, 2007 BurnsAdler and Serral Enter into a Promotional Agreement
   

Aug 01, 2006

BurnsAdler Licenses Gentamicin Surgical Implant from Innocoll

   

Feb 01, 2006

 New Promotion Agreement with Sigma-Tau
   
Nov 08, 2005 Nitronal® Infusion Approved for Sale in Mexico
   
Feb 18, 2005 BurnsAdler Partners with Sigma-Tau S.p.A. to Promote Natulan®
   
Feb 09, 2005 BurnsAdler Partners to Expand Puerto Rico Franchise
 
Sep 07, 2004 Giancarlo Mennella, M.D. Named to Advisory Board
 
Mar 05, 2004 BurnsAdler Licenses Anti-Epileptic Portfolio from Desitin Arzneimittel GmbH
 
Jun 30, 2004 BurnsAdler Pharmaceuticals, Inc. Licenses NeoVisc® from Stellar Pharmaceuticals, Inc. 
 
Jun 17, 2003 BurnsAdler Pharmaceuticals, Inc. Licenses Nitrolingual® Pumpspray and Nitronal® IV Infusion from G. Pohl-BoskampGmbH & Co.